Sinclair Pharma (SPH)

 

SPH Share PerformanceMore

52 week high61.330 07/12/15
52 week low26.000 28/09/16
52 week change -9.750 (-26.35%)
4 week volume28,443,110 03/09/16

Latest NewsMore

Holding(s) in Company

RNS Number: 2368L Sinclair Pharma PLC 29 September 2016 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Sinclair Pharma PLC 2 Reason for the notification (ple...

Additional Listing

RNS Number: 1036L Sinclair Pharma PLC 28 September 2016 Sinclair Pharma plc Additional listing - Replacement The following announcement replaces the one issued by Sinclair Pharma plc on 26 September 2016 with RNS number 8633K. The total number of new ordinary shares of 1p each for which application is being made is 4,674,735 and not 4,674,900. London...

Director/PDMR Shareholding

RNS Number: 9909K Sinclair Pharma PLC 27 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1. Details of the person discharging managerial responsibilities / person closely associated a. Name Chris Spooner 2. Reason for the notification a. Position/status Chie...

Director/PDMR Shareholding

RNS Number: 9905K Sinclair Pharma PLC 27 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1. Details of the person discharging managerial responsibilities / person closely associated a. Name Alan Olby 2. Reason for the notification a. Position/status Chief Fi...

Additional Listing

RNS Number: 8633K Sinclair Pharma PLC 26 September 2016 Sinclair Pharma plc Additional listing London , 26 September 2016 Sinclair Pharma plc ( SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that a total of 4,674,900 new ordinary shares of 1p each (the "New Ordinary Shares") have been issued and allotted pursuant to t...

Holding(s) in Company

RNS Number: 5913K Sinclair Pharma PLC 22 September 2016 For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Sinclair Pharma PLC 2 Reason for the notification (ple...

Sinclair Pharma more than halves H1 pretax loss

Sinclair Pharma has more than halved its H1 pretax loss to 3.4m, from a loss of 7.2m. Revenue was marginally lower at 17.2...

Half-year Report

RNS Number: 3808K Sinclair Pharma PLC 21 September 2016 Sinclair Pharma plc Delivering strong growth, completed transformational US distribution deal, on track to meet full year guidance Sinclair Pharma plc (SPH.L), ("Sinclair", or the "Group", or the "Company") the international specialty pharma company, today announces its unaudited results for the six a...

Fundamental DataMore

EPS-1.5
Dividend yield0 %

Latest discussion posts More

  • Re: Results

    I suspect that investors do not like the t/o level required for profit. Mind you, 125% compound increase for 2 years would do the trick! E
    29-Sep-2016
    Eaglehurst
  • Results

    Results initially seemed to be well received, according to the SP at least. Unless I am missing something, most everything appears positive. Sadly SP gains didn't hold. Maybe ...
    21-Sep-2016
    charlus
  • Re: Results

    "Sinclair?s interim results for the six-month period to 30th June are in line with expectations and the company?s trading update in July, with revenue of #17.3m and a strong ...
    21-Sep-2016
    Sambram

Users' HoldingsMore

Users who hold Sinclair Pharma also hold..
LLOYDS GRP.34%
BP23%
BARCLAYS22%
ROYAL BANK SCOT19%
VODAFONE GRP.19%

Codes & Symbols

ISINGB0033856740
SymbolsSPH, LSE:SPH, SPH.L, SPH:LN, LON:SPH, XLON:SPH